This is the current revision of this page, as edited by Arthurfragoso (talk | contribs) at 19:16, 14 August 2023 (Brazil + Drug classes F1, F2, F3, F4). The present address (URL) is a permanent link to this version.
Revision as of 19:16, 14 August 2023 by Arthurfragoso (talk | contribs) (Brazil + Drug classes F1, F2, F3, F4)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This is the template sandbox page for Template:Infobox drug/legal status (diff). |
Template documentation[view] [edit] [history] [purge]
FDA-2023
- Infobox drug/legal status/sandbox (edit · t · history · diff · links · /test · Source · e · t · hist · links · /subpages · /doc · /doc edit)
generic
This is a second sandbox (sandbox #2) for {{Infobox drug}} (talk). It is created to allow parallel development, without disturbing ../sandbox development.
- diff with live version.
- Subtemplates /sandbox may have a diff too. That's for the editor (you?) to keep in mind.
- See also: Template:Infobox drug/testcases2.
Note that one sandbox goes live, the other one should be updated to reflect the new live source.
The above documentation is transcluded from Template:Infobox drug/sandbox2/doc. (edit | history)Editors can experiment in this template's sandbox (edit | diff) and testcases (create) pages.
Subpages of this template. Category: